General practitioners' continuing medical education: a prospective study from the County of Aarhus.

Participation of Danish general practitioners (GPs) in continuing medical education (CME) has often been the subject of debate, although very little is known about the extent and content of activities. One-hundred-and-sixty-one Danish GPs participated in this one-year prospective study by collecting data on their own CME activities. We received 9980 data registration charts.

[Continuing medical education of general practitioners. A prospective study from the Aarhus county].

Introduction: Danish general practitioners' (GPs') participation in continuing medical education (CME) has often been the subject of debate, but actually very little is known about the extent and the contents of the activities.

Material And Methods: One hundred and sixty-one Danish GPs participated in this one-year prospective study by collecting data on their own CME activities.

Results: We received 9980 data registration sheets.

[How do pharmacists evaluate the newly introduced system of substituting prescriptions?].

In 1997 a new prescription system was introduced in the Danish health care system. The pharmacist must now substitute a prescription with a cheaper version of the drug (either generic or original) unless the prescribing doctor indicates that substitution is not allowed in the specific case. The purpose of this study was to evaluate problems of the system and obtain the pharmacists' views on the system.

[How do practitioners evaluate the newly introduced system of substituting prescriptions?].

Aims: In 1997 a new prescription system was introduced in the Danish health care system. The pharmacist must now substitute a prescribed drug with a cheaper version, either generic (G-substitution) or original (O-substitution) unless the general practitioner (GP) indicates that substitution is not allowed. The purpose of this study was to obtain the GPs' views on the system and evaluate the problems related to the system.

[How do patients evaluate the newly introduced system of substituting prescriptions?].

In 1997 a new prescription system was introduced in Denmark. The pharmacist must now substitute the prescribed drug with a cheaper version either by a generic prescription (G-substitution) or by an original prescription (O-substitution) unless the prescribing doctor indicates that substitution is not allowed in the specific case. The purpose of this study was to obtain the patients' view on the new prescription system and to identify any related problems.